IMMUNOCORE HOLDINGS PLC

13119746
Active Abingdon
524 employees website.com
Life sciences and medical technology
I

IMMUNOCORE HOLDINGS PLC

13119746
Founded 7 Jan 2021 Active Abingdon, United Kingdom 524 employees website.com
Life sciences and medical technology

Previous Company Names

IMMUNOCORE HOLDINGS LIMITED 7 Jan 2021 — 1 Feb 2021
Accounts Due 30 Jun 2026 5 days remaining
Confirmation Submitted 3 Feb 2026 Next due 20 Jan 2027 6 months remaining
Net assets £381M £94M 2025 year on year
Total assets £1,067M £263M 2025 year on year
Total Liabilities £686M £169M 2025 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

92 Park Drive Milton Park Abingdon Oxfordshire OX14 4RY United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for IMMUNOCORE HOLDINGS PLC (13119746), an active life sciences and medical technology company based in Abingdon, United Kingdom. Incorporated 7 Jan 2021. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 5 days remaining

Balance Sheet & P&L (2018–2025)

Cash in Bank

£864.15M

Increased by £210.23M (+32%)

Net Assets

£381.03M

Increased by £93.51M (+33%)

Total Liabilities

£686.24M

Increased by £169.09M (+33%)

Turnover

£419.74M

Increased by £161.17M (+62%)

Employees

524

Increased by 27 (+5%)

Debt Ratio

64%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

595 Allotments 24,820,915,094 Shares £451.54m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 May 20269,285£192k£20.709
4 May 20263,000£65k£21.547
4 May 20263,000£65k£21.643
4 May 20261,659£36k£21.85
4 May 202665,000£1.43m£22.002

Officers

Officers

3 active
Status
Peter John RatcliffeDirectorBritishUnited Kingdom7222 Jan 2021Active
Ranjeev KrishanaDirectorAmericanUnited States5228 May 2024Active
Roy Steven HerbstDirectorAmericanUnited States6328 Jan 2021Active

Shareholders

Shareholders (5)

National City Nominees Limited Citigroup Centre Canada Square Canary Wharf London E14 5le
82.3%
43,861,622
Immunocore Nominees Limited 92 Park Drive Milton Park Abingdon Oxfordshire Ox14 4ry
10.9%
5,793,500

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

John Irving Bell

Ceased 22 Jan 2021

Ceased

Group Structure

Group Structure

IMMUNOCORE HOLDINGS PLC Current Company
IMMUNOCORE LIMITED united kingdom

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jun 2026CapitalAllotment of shares (GBP 102,618.9281) on 22 May 2026
12 May 2026CapitalAllotment of shares (GBP 102,310.4981) on 23 Apr 2026
7 May 2026CapitalAllotment of shares (GBP 102,241.9021) on 25 Mar 2026
29 Apr 2026CapitalCapital Name Of Class Of Shares
13 Apr 2026CapitalAllotment of shares (GBP 102,239.8041) on 17 Mar 2026
8 Jun 2026 Capital

Allotment of shares (GBP 102,618.9281) on 22 May 2026

12 May 2026 Capital

Allotment of shares (GBP 102,310.4981) on 23 Apr 2026

7 May 2026 Capital

Allotment of shares (GBP 102,241.9021) on 25 Mar 2026

29 Apr 2026 Capital

Capital Name Of Class Of Shares

13 Apr 2026 Capital

Allotment of shares (GBP 102,239.8041) on 17 Mar 2026

Recent Activity

Latest Activity

Allotment of shares (GBP 102,618.9281) on 22 May 2026

2 weeks ago on 8 Jun 2026

Allotment of shares (GBP 102,310.4981) on 23 Apr 2026

1 months ago on 12 May 2026

Allotment of shares (GBP 102,241.9021) on 25 Mar 2026

1 months ago on 7 May 2026

Capital Name Of Class Of Shares

1 months ago on 29 Apr 2026

Allotment of shares (GBP 102,239.8041) on 17 Mar 2026

2 months ago on 13 Apr 2026